2Kreitman RJ. Immunotoxins in cancer therapy. Cancer,2000,570-578.
3Inoue K, Sugiyama H,Ogawa H,et al. Expression of the interleukin-6, IL6 receptor and gp130 genes in acute leukemia. Blood, 1994,84:2672-2675.
4Boayue KB, Gu L, Yeager AM, et al. Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-pseudomonas exotoxin. Leukemia,1998,12:182-186.
5Kreitman RJ. Pastan I. Accumulation of a recombinant immunotoxin in a tumor in vivo: fewer than 1000 molecules per cell are sufficient for complete responses. Cancer Res,1998,58:968- 975.
6Kreitman RJ, Pastan I. Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor. Biochem J,1995,307:29-37.
7Sambrood J, Fritxch EF, Maniatis T. Molecular cloning: a laboratory manual,New York:Cold Spring Harbor Laboratory Press,1989.
8TU J L, KARASAVVAS N, HEANEY M L, et al.Molecular characterization of a granulocyte macrophage-colony-stimulating factor receptor α subnuit-associated protein[J]. Blood,2000, 96:794--799.
9LILLY M B, ZEMSKOVA M, FRANKEL A E, et al. Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptorαsubunit mediate activation of Jak/Stat signaling and differentiation[J]. Blood, 2001, 97:1662-1670.
